FX, the announcement you refer to typifies the reporting style of Biotron.
The headline says the trial cures HCV. (Not BIT225)
Then...
Biotron achieves SVR12 bla bla bla. (Not BIT225)
Nowhere do they say BIT225 cures HCV because it doesn't.
In paragraph four they talk of the other two drugs they took for a year.
- Forums
- ASX - By Stock
- BIT
- Idenix
Idenix, page-21
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.6¢ | 2.7¢ | 2.6¢ | $438 | 16.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 125551 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 157830 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 125551 | 0.026 |
5 | 365000 | 0.025 |
3 | 3474583 | 0.024 |
1 | 130000 | 0.023 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 157830 | 2 |
0.028 | 145600 | 2 |
0.029 | 260000 | 2 |
0.030 | 49844 | 3 |
0.031 | 280868 | 5 |
Last trade - 12.25pm 15/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online